These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10628797)

  • 21. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
    Pasz-Walczak G; Kordek R
    Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.
    Harada N; Gansauge S; Gansauge F; Gause H; Shimoyama S; Imaizumi T; Mattfeld T; Schoenberg MH; Beger HG
    Br J Cancer; 1997; 76(3):299-305. PubMed ID: 9252195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of p21/waf1/cip1 in colorectal cancer.
    Zirbes TK; Baldus SE; Moenig SP; Nolden S; Kunze D; Shafizadeh ST; Schneider PM; Thiele J; Hoelscher AH; Dienes HP
    Int J Cancer; 2000 Jan; 89(1):14-8. PubMed ID: 10719725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
    Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
    Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer.
    Veloso M; Wrba F; Kaserer K; Heinze G; Magalhães A; Herbst F; Teleky B
    Virchows Arch; 2000 Sep; 437(3):241-7. PubMed ID: 11037343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
    Pasz-Walczak G; Kordek R; Faflik M
    Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.
    Yasui W; Akama Y; Yokozaki H; Semba S; Kudo Y; Shimamoto F; Tahara E
    Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
    Qin LF; Ng IO; Fan ST; Ng M
    Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p21 expression and mutation in gastric carcinoma: analysis by immunohistochemistry and PCR-SSCP.
    Park YE; Choi KC; Choi YH
    J Korean Med Sci; 1998 Oct; 13(5):507-12. PubMed ID: 9811180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p21WAF1/CIP1 expression in primary lung adenocarcinomas: heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities.
    Takeshima Y; Yamasaki M; Nishisaka T; Kitaguchi S; Inai K
    Carcinogenesis; 1998 Oct; 19(10):1755-61. PubMed ID: 9806155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas.
    Valassiadou KE; Stefanaki K; Tzardi M; Datseris G; Georgoulias V; Melissas J; Tsiftsis DD; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(4A):2571-6. PubMed ID: 9252682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen AL
    J Pathol; 1997 Feb; 181(2):140-5. PubMed ID: 9120716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
    J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53.
    Chendil D; Oakes R; Alcock RA; Patel N; Mayhew C; Mohiuddin M; Gallicchio VS; Ahmed MM
    Cancer; 2000 Nov; 89(9):1893-900. PubMed ID: 11064345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
    Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Bertacca G; Chella A; Merlo G; Angeletti CA; Dalla Palma P; Bevilacqua G
    Oncogene; 1996 Mar; 12(6):1319-24. PubMed ID: 8649834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.